Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem Cells

Tumor-infiltrating lymphocytes (TIL) that can recognize and kill tumor cells have curative potential in subsets of patients treated with adoptive cell transfer (ACT). However, lack of TIL therapeutic efficacy in many patients may be due in large part to a paucity of tumor-reactive T cells in TIL and...

Descripción completa

Detalles Bibliográficos
Autores principales: Islam, S.M. Rafiqul, Maeda, Takuya, Tamaoki, Naritaka, Good, Meghan L., Kishton, Rigel J., Paria, Biman C., Yu, Zhiya, Bosch-Marce, Marta, Bedanova, Nicole M., Liu, Chengyu, Kruhlak, Michael J., Restifo, Nicholas P., Vizcardo, Raul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10211394/
https://www.ncbi.nlm.nih.gov/pubmed/37377887
http://dx.doi.org/10.1158/2767-9764.CRC-22-0265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10211394/
https://www.ncbi.nlm.nih.gov/pubmed/37377887
http://dx.doi.org/10.1158/2767-9764.CRC-22-0265

Ejemplares similares